(Center for Genomic Regulation) A research effort led by Eulàlia Martí at the Centre for Genomic Regulation reveals new molecular mechanisms of Huntington's chorea. The results, recently published in the Journal of Clinical Investigation, question the approaches used up to now for treatment of the disease. They also point to messenger RNA as a key pathogenic component that will make it possible to define new therapeutic strategies.
The messenger in Huntington’s disease
Please login to join discussion
POPULAR NEWS
-
Understanding rapid tendon regeneration in newts may one day help human athletes
-
Study finds increasingly popular oral nicotine pouches do little to curb smokers’ cravings
-
SMART researchers pioneer novel microfluidic method to optimise bone marrow stem cell extraction for advanced cell therapies
-
UMass Amherst receives $2.5 million from Howard Hughes Medical Institute to reshape STEM education